Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy: A Randomized Clinical Trial.
Oudard S, Latorzeff I, Caty A, Miglianico L, Sevin E, Hardy-Bessard AC, Delva R, Rolland F, Mouret L, Priou F, Beuzeboc P, Gravis G, Linassier C, Gomez P, Voog E, Muracciole X, Abraham C, Banu E, Ferrero JM, Ravaud A, Krakowski I, Lagrange JL, Deplanque G, Zylberait D, Bozec L, Houede N, Culine S, Elaidi R. Oudard S, et al. Among authors: muracciole x. JAMA Oncol. 2019 May 1;5(5):623-632. doi: 10.1001/jamaoncol.2018.6607. JAMA Oncol. 2019. PMID: 30703190 Free PMC article. Clinical Trial.
Subcutaneous interleukin-2 and interferon alfa administration in patients with metastatic renal cell carcinoma: final results of SCAPP III, a large, multicenter, phase II, nonrandomized study with sequential analysis design--the Subcutaneous Administration Propeukin Program Cooperative Group.
Tourani JM, Pfister C, Tubiana N, Ouldkaci M, Prevot G, Lucas V, Oudard S, Malet M, Cottu P, Ferrero JM, Mayeur D, Rixe O, Sun XS, Bernard O, Andre T, Tournigand C, Muracciole X, Guilhot J; Subcutaneous Administration Propeukin Program Cooperative Group. Tourani JM, et al. Among authors: muracciole x. J Clin Oncol. 2003 Nov 1;21(21):3987-94. doi: 10.1200/JCO.2003.02.073. J Clin Oncol. 2003. PMID: 14581421 Clinical Trial.
Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults.
Padovani L, Sunyach MP, Perol D, Mercier C, Alapetite C, Haie-Meder C, Hoffstetter S, Muracciole X, Kerr C, Wagner JP, Lagrange JL, Maire JP, Cowen D, Frappaz D, Carrie C. Padovani L, et al. Among authors: muracciole x. Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):433-40. doi: 10.1016/j.ijrobp.2006.12.030. Int J Radiat Oncol Biol Phys. 2007. PMID: 17498567
Cost of prostate image-guided radiation therapy: results of a randomized trial.
Perrier L, Morelle M, Pommier P, Lagrange JL, Laplanche A, Dudouet P, Supiot S, Chauvet B, Nguyen TD, Crehange G, Beckendorf V, Pene F, Muracciole X, Bachaud JM, Le Prisé E, de Crevoisier R. Perrier L, et al. Among authors: muracciole x. Radiother Oncol. 2013 Jan;106(1):50-8. doi: 10.1016/j.radonc.2012.11.011. Epub 2013 Jan 17. Radiother Oncol. 2013. PMID: 23333022 Free article. Clinical Trial.
Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2.
Oudard S, Culine S, Vano Y, Goldwasser F, Théodore C, Nguyen T, Voog E, Banu E, Vieillefond A, Priou F, Deplanque G, Gravis G, Ravaud A, Vannetzel JM, Machiels JP, Muracciole X, Pichon MF, Bay JO, Elaidi R, Teghom C, Radvanyi F, Beuzeboc P. Oudard S, et al. Among authors: muracciole x. Eur J Cancer. 2015 Jan;51(1):45-54. doi: 10.1016/j.ejca.2014.10.009. Epub 2014 Nov 15. Eur J Cancer. 2015. PMID: 25459391 Clinical Trial.
Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized Trial.
de Crevoisier R, Bayar MA, Pommier P, Muracciole X, Pêne F, Dudouet P, Latorzeff I, Beckendorf V, Bachaud JM, Laplanche A, Supiot S, Chauvet B, Nguyen TD, Bossi A, Créhange G, Lagrange JL. de Crevoisier R, et al. Among authors: muracciole x. Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1420-1429. doi: 10.1016/j.ijrobp.2018.07.2006. Epub 2018 Jul 31. Int J Radiat Oncol Biol Phys. 2018. PMID: 30071296 Clinical Trial.
HoSAGE: sarcopenia in older patient with intermediate / high-risk prostate cancer, prevalence and incidence after androgen deprivation therapy: study protocol for a cohort trial.
Couderc AL, Villani P, Berbis J, Nouguerède E, Rey D, Rossi D, Lechevallier É, Badinand D, Bastide C, Karsenty G, Boissier R, Amichi K, Muracciole X. Couderc AL, et al. Among authors: muracciole x. BMC Cancer. 2022 Jan 18;22(1):78. doi: 10.1186/s12885-021-09105-8. BMC Cancer. 2022. PMID: 35042460 Free PMC article.
79 results